1[1]Mochizuki H, Mori H, Mizuno Y. Apoptosis in neurodegererative disorders. J Neural Transm Suppl, 1997; 50: 25～140
2[2]Bains JS, Shaw JA. Neurodegenerative disoders in human: the role of glutathione in oxidative stress-mediated neuronal death. Brain Res Rev, 1997; 25(3):335～358
3[3]Przedborski S, Jackson-lewis V. Mechanisms of MPTP toxicity. Mov Disord, 1998; 13 Suppl 1: 35～38
4[4]Woodgate A, Macgibbon G, Walton M et al. The toxicity of 6-OHDA on PC12 and PC19 cells. Brain ResMol Brain Res, 1999; 69(1): 84～92
5[5]Naoi M, Maruyama W. Cell death of dopamine neurons in aging and Parkinson's disease. Mech Aging Dev, 1999; 111(2-3):175～188
6[6]Hansson O, Castilho RF, Kaminski Schierle GS et al. Additive effects of caspase inhibitor and lazaroid on the survival of transplanted and human embryonic dopamine neurons. Exp Neurol, 2000; 164(1):102～111
7[7]Jiang Q, Gu Z, Zhong G et al. Diphosphorylation and involvement of apoptotic-like death in cultured rat cortical neurons. Brain Res. 2000; 857(1-2): 71～77
8[8]Przedborski S, Jackson-lewis V, Yokoyama R et al. Role of neuronal nitric oxide in MPTP-induced dopaminergic neurotoxicity. Proc Natl Acad Sci USA. 1999; 93:4565～4571
9[9]Lavoie M, Hastings TG. Peroxynitrite-and nitrite-induced oxidation of dopamine: implications for nitric oxide in dopaminergic cell loss. J Neurochem, 1999; 73(6):2546～2554
10[10]Rodnitzky RL. Can calcium antaganistis provide a neuroprotective effect in Parkinson's disease. Drugs 1999; 57(6):845～849
